ASTH Long Call Strategy
ASTH (Astrana Health, Inc.), in the Healthcare sector, (Medical - Care Facilities industry), listed on NASDAQ.
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients.
ASTH (Astrana Health, Inc.) trades in the Healthcare sector, specifically Medical - Care Facilities, with a market capitalization of approximately $1.97B, a trailing P/E of 64.25, a beta of 0.99 versus the broader market, a 52-week range of 18.08-39.93, average daily share volume of 491K, a public-listing history dating back to 2009, approximately 2K full-time employees. These structural characteristics shape how ASTH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.99 places ASTH roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 64.25 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a long call on ASTH?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current ASTH snapshot
As of May 15, 2026, spot at $38.06, ATM IV 53.90%, IV rank 32.96%, expected move 15.45%. The long call on ASTH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on ASTH specifically: ASTH IV at 53.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 15.45% (roughly $5.88 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ASTH expiries trade a higher absolute premium for lower per-day decay. Position sizing on ASTH should anchor to the underlying notional of $38.06 per share and to the trader's directional view on ASTH stock.
ASTH long call setup
The ASTH long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ASTH near $38.06, the first option leg uses a $38.06 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ASTH chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ASTH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $38.06 | N/A |
ASTH long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
ASTH long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on ASTH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on ASTH
Long calls on ASTH express a bullish thesis with defined risk; traders use them ahead of ASTH catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
ASTH thesis for this long call
The market-implied 1-standard-deviation range for ASTH extends from approximately $32.18 on the downside to $43.94 on the upside. A ASTH long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ASTH IV rank near 32.96% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on ASTH should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ASTH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ASTH-specific events.
ASTH long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ASTH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ASTH alongside the broader basket even when ASTH-specific fundamentals are unchanged. Long-premium structures like a long call on ASTH are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ASTH chain quotes before placing a trade.
Frequently asked questions
- What is a long call on ASTH?
- A long call on ASTH is the long call strategy applied to ASTH (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ASTH stock trading near $38.06, the strikes shown on this page are snapped to the nearest listed ASTH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ASTH long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ASTH long call priced from the end-of-day chain at a 30-day expiry (ATM IV 53.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ASTH long call?
- The breakeven for the ASTH long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ASTH market-implied 1-standard-deviation expected move is approximately 15.45%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on ASTH?
- Long calls on ASTH express a bullish thesis with defined risk; traders use them ahead of ASTH catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current ASTH implied volatility affect this long call?
- ASTH ATM IV is at 53.90% with IV rank near 32.96%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.